102 results match your criteria: "the London Chest Hospital[Affiliation]"
J Am Coll Cardiol
November 2014
Centre for Advanced Cardiovascular Imaging, Queen Mary University of London, The London Chest Hospital, London, United Kingdom. Electronic address:
Background: Left ventricular (LV) trabeculation is highly variable among individuals and is increased in some diseases (e.g., congenital heart disease or cardiomyopathies), but its significance in population-representative individuals is unknown.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
November 2014
From the Department of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Middlesex, United Kingdom (M.B.I., C.I., T.K., R.S., R.L., M.M., P.C., M.D.); Department of Cardiology, UCL Hospitals NHS Foundation Trust, Heart Hospital, London, United Kingdom (T.C., P. Meier); Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom (S.K., P. MacCarthy); Department of Cardiology, Barts Health NHS Trust, The London Chest Hospital, London, United Kingdom (C.K., A.M., D.B., K.R.); Department of Cardiology, St. George's Healthcare NHS Foundation Trust, St. George's Hospital, London, United Kingdom (S.F., P.L.); Department of Cardiology, Imperial College Healthcare NHS Foundation Trust, Hammersmith Hospital, London, United Kingdom (I.S.M.); Department of Cardiology, Royal Free London NHS Foundation Trust, London, United Kingdom (R.D.R.); Department of Cardiology, BHF Centre of Excellence, King's College London, St. Thomas Hospital, London, United Kingdom (S.R.); and Department of Cardiology, London Ambulance Service, London, United Kingdom (M.W.).
Background: It is estimated that up to two thirds of patients presenting with ST-segment-elevation myocardial infarction have multivessel disease. The optimal strategy for treating nonculprit disease is currently under debate. This study provides a real-world analysis comparing a strategy of culprit-vessel intervention (CVI) versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction.
View Article and Find Full Text PDFObjective: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical decision-making in hypertrophic cardiomyopathy (HCM). The primary aims of this study were to examine the phenotypes associated with sarcomere protein (SP) gene mutations and test the hypothesis that variation in non-sarcomere genes modifies the phenotype.
Methods: Unrelated and consecutive patients were clinically evaluated and prospectively followed in a specialist clinic.
Interv Cardiol
August 2014
Interventional Cardiologist and Head of the Transcatheter Aortic Valve Implantation Programme at the London Chest Hospital, Barts Health NHS Trust, London. He trained at Manchester University, St Bartholomew's Hospital, the London Chest Hospital and St Vincent's Hospital, Melbourne. His research interests relate to aortic valve and coronary interventions.
Circ Cardiovasc Interv
August 2014
From the Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Middlesex, United Kingdom (M.B.I., A. Arujuna, C.I., M.D.); UCL Hospitals NHS Foundation Trust, Heart Hospital, London, United Kingdom (T.C., P. Meier); Kings College Hospital, King's College Hospital NHS Foundation Trust, London, United Kingdom (S.K., P. MacCarthy); Barts Health NHS Trust, The London Chest Hospital, London, United Kingdom (A. Archbold, C.K., A.M., D.B., K.R., A.W.); St. George's Healthcare NHS Foundation Trust, St. George's Hospital, London, United Kingdom (S.F., P.L.); Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (I.S.M.); Royal Free London NHS Foundation Trust, London, United Kingdom (R.D.R.); BHF Centre of Excellence, Kings College London, St. Thomas' Hospital, London, United Kingdom (S.R.); and London Ambulance Service, London, United Kingdom (M.W.).
Background: Compared with transfemoral access, transradial access (TRA) for percutaneous coronary intervention is associated with reduced risk of bleeding and vascular complications. Studies suggest that TRA may reduce mortality in patients with ST-segment-elevation myocardial infarction. However, there are few data on the effect of TRA on mortality, specifically, in patients with non-ST-segment-elevation myocardial infarction.
View Article and Find Full Text PDFNucl Med Commun
August 2014
aDepartment of Cardiology, The London Chest Hospital bInstitute of Nuclear Medicine, University College London Hospital cBritish Heart Foundation Laboratories, University College London, London, UK dSection of Cardiovascular Medicine, School of Medicine, Yale University, New Haven, Connecticut, USA eDepartment of Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden fCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Background: Bone marrow stem cell (BMSC) therapy for cardiovascular disease has shown considerable preclinical and clinical promise, but there remains a need for mechanistic studies to help bridge the transition from bench to bedside. We have designed a substudy to our REGENERATE-IHD trial (ClinicalTrial.gov Identifier: NCT00747708) to assess the feasibility of a novel imaging technique to detect angiogenesis following BMSC therapy.
View Article and Find Full Text PDFInterv Cardiol
April 2014
Interventional Cardiologist and Head of the Transcatheter Aortic Valve Implantation Programme at the London Chest Hospital, Barts Health NHS Trust, London. He trained at Manchester University, St Bartholomew's Hospital, the London Chest Hospital and St Vincent's Hospital, Melbourne. His research interests relate to aortic valve and coronary interventions.
Interv Cardiol
March 2014
Interventional Cardiologist and Head of the Transcatheter Aortic Valve Implantation Programme at the London Chest Hospital, Barts Health NHS Trust, London. He trained at Manchester University, St Bartholomew's Hospital, the London Chest Hospital and St Vincent's Hospital, Melbourne. His research interests relate to aortic valve and coronary interventions.
Heart
August 2014
Institute for Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
JACC Cardiovasc Imaging
September 2013
Advanced Cardiovascular Imaging, William Harvey Research Institute, National Institute for Health Research, Cardiovascular Biomedical Research Unit at Barts, The London Chest Hospital, London, United Kingdom. Electronic address:
Int J Cardiovasc Imaging
December 2013
Advanced Cardiovascular Imaging, Centre for Advanced Cardiovascular Imaging, NIHR Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, The London Chest Hospital, Queen Mary University of London, Bonner Road, London, E2 9JX, UK,
Restoration of sinus rhythm may result in an improvement of left heart function in patients with atrial fibrillation (AF). Cardiovascular magnetic resonance (CMR) feature tracking (FT) technique may help detect subtle wall-motion abnormalities. Consequently this study aimed to analyse existence and reversibility of subclinical cardiac dysfunction following atrial fibrillation ablation.
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
January 2014
Centre for Advanced Cardiovascular Imaging, NIHR Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London School of Medicine and Barts Health NHS Trust, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
Aims: The severity of coronary artery narrowing is a poor predictor of functional significance, in particular in intermediate coronary lesions (30-70% diameter narrowing). The aim of this work was to compare the performance of a quantitative hyperaemic myocardial blood flow (MBF) index derived from adenosine dynamic computed tomography perfusion (CTP) imaging with that of visual CT coronary angiography (CTCA) and semi-automatic quantitative CT (QCT) in the detection of functionally significant coronary lesions in patients with stable chest pain.
Methods And Results: CTCA and CTP were performed in 80 patients (210 analysable coronary vessels) referred to invasive coronary angiography (ICA).
Respir Med
November 2013
Department of Respiratory Medicine, The London Chest Hospital, Barts Health NHS Trust, London E2 9JX, UK; Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, NIHR Cardiovascular Biomedical Research Unit at Barts, The London Chest Hospital, London E2 9JX, UK.
Significant cardiovascular morbidity and mortality exists in chronic obstructive pulmonary disease (COPD). Arterial stiffness is raised in COPD and may be a mechanistic link. Non-invasive assessment of arterial stiffness has the potential to be a surrogate outcome measure, although no reproducibility data exists in COPD patients.
View Article and Find Full Text PDFJ Cardiovasc Magn Reson
May 2013
Centre Lead for Advanced Cardiovascular Imaging, William Harvey Research Institute, NIHR Cardiovascular Biomedical Research Unit at Barts, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
UK Biobank is a prospective cohort study with 500,000 participants aged 40 to 69. Recently an enhanced imaging study received funding. Cardiovascular magnetic resonance (CMR) will be part of a multi-organ, multi-modality imaging visit in 3-4 dedicated UK Biobank imaging centres that will acquire and store imaging data from 100,000 participants (subject to successful piloting).
View Article and Find Full Text PDFJ Asthma
June 2013
Department of Respiratory Medicine, The London Chest Hospital, Barts Health NHS Trust, London, United Kingdom.
Objective: The aim of this study was to evaluate the "real world" effects of the monoclonal antibody omalizumab (OMB) when used to treat severe persistent allergic asthma in UK clinical practice.
Methods: A 10-center retrospective observational study was carried out to compare oral corticosteroid (OCS) use and exacerbation frequency in 12 months pre- versus post-OMB initiation in 136 patients aged ≥12 years with severe persistent allergic asthma. All patients received ≥1 dose of OMB.
Br J Hosp Med (Lond)
April 2013
The London Chest Hospital, Barts Health, London, UK.
Interact Cardiovasc Thorac Surg
March 2013
Department of Cardiothoracic Surgery, The London Chest Hospital, London, UK.
A best evidence topic was written according to a structured protocol, asking 'does surgery improve prognosis in patients with small-cell lung carcinoma (SCLC)?' One hundred and thirteen papers were identified, of which the nine papers best able to answer the question were selected and the details of each tabulated. The prohibitive attitude of clinicians toward surgery in SCLC has prevailed since the 1960s, informed by a prospective randomized trial in which 144 patients were assigned to surgical treatment or to radical radiotherapy. Surgery conferred no survival benefit when compared with radical radiotherapy as assessed at 6 monthly intervals up to 10 years post-treatment.
View Article and Find Full Text PDFHeart
July 2012
Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Barts and the London National Institute of Health Research Biomedical Research Unit, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
Significant cardiac morbidity and mortality exists in patients with COPD. Shared risk factors include age, smoking history and exposure to air pollution and passive smoke. Although the inappropriate under-prescribing of β-blockers contributes, it is now appreciated that the observed cardiac risk is not only due to smoking and conventional cardiovascular risk factors, but also other independent factors.
View Article and Find Full Text PDFInteract Cardiovasc Thorac Surg
September 2012
Department of Cardiothoracic Surgery, The London Chest Hospital, London, UK.
A best evidence topic was written according to a structured protocol in order to identify the mode of anticoagulation that has the best safety profile for both the mother and the foetus in pregnant patients with mechanical prosthetic heart valves. A total of 281 papers were identified using the reported search, of which eight represented the best evidence to answer the clinical question. The authors, date, journal, study type, population, main outcome measures and results are tabulated.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2012
Department of Cardiology, The London Chest Hospital, Barts, United Kingdom.
Objectives: Renal impairment (RI) is a predictor of poor outcomes in patients with cardiovascular disease, but its influence in the setting of percutaneous coronary intervention and zotarolimus-eluting stent (ZES) implantation has not been described. This study evaluated the impact of RI on clinical outcomes in patients participating in the E-Five Registry.
Background: E-Five was a prospective, multicenter, global registry of 8,314 patients; 2,116 patients were followed to 2 years.
Interact Cardiovasc Thorac Surg
July 2012
Department of Cardiothoracic Surgery, The London Chest Hospital, London, UK.
We addressed the question of whether or not the currently available evidence base supports heparinization in the context of a patient requiring cardiovascular support with an intra-aortic balloon pump (IABP). A best evidence topic was written according to a previously defined structured protocol. A literature search returned 443 papers, 3 of which were deemed relevant.
View Article and Find Full Text PDFCurr Opin Pulm Med
May 2012
The London Chest Hospital, and Department of Infectious Diseases, University College London Medical School, London, UK.
Purpose Of Review: Tuberculosis (TB) remains a global emergency and continues to kill 1.7 million people globally each year. In the UK, figures for TB are increasing especially in urban areas.
View Article and Find Full Text PDFInteract Cardiovasc Thorac Surg
March 2012
Department of Cardiothoracic Surgery, The London Chest Hospital, London, UK.
A best evidence topic was written according to a structured protocol. The question addressed was whether video-assisted mediastinoscopy (VAM) has a better lymph node yield and safety profile than the conventional mediastinoscopy (CM). A total of 194 papers were found, using the reported searches, of which five represented the best evidence to answer the clinical question.
View Article and Find Full Text PDFInteract Cardiovasc Thorac Surg
August 2011
Department of Cardiothoracic Surgery, The London Chest Hospital, London, UK.
A best evidence topic was written according to a structured protocol. The question addressed was, in what proportion of patients is the nerve of Kuntz identifiable? A total of 55 papers were found using the reported search, of which six represented the best evidence to answer the clinical question. The authors, date, journal, study type, population, main outcome measures and results are tabulated.
View Article and Find Full Text PDFInteract Cardiovasc Thorac Surg
August 2011
Department of Cardiothoracic Surgery, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
A best evidence topic was written according to a structured protocol. The question addressed was 'Is it safe to perform coronary angiography (CA) in acute endocarditis?' Three hundred and ninety-seven papers were found using the reported search, of which six represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes, key results and limitations of these papers are tabulated.
View Article and Find Full Text PDF